| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |